Long-term treatment with VYVANSE, first prodrug stimulant, demonstrates significant efficacy in ADHD

ch improved" by physicians on the Clinical Global Impressions-Improvement (CGI-I) scale, a secondary endpoint.

All 272 patients in the long-term trial previously participated in either of two double-blind clinical trials of VYVANSE. In the long-term trial, investigators provided participants with 30 mg once-daily doses of VYVANSE for one week, and then adjusted the dosage by 20 mg at weekly intervals during three subsequent visits to achieve optimal efficacy and tolerability. Participants continued treatment for the remaining 11 months. The maximum daily dose was 70 mg.

Safety was also evaluated during the study and VYVANSE was generally well tolerated. Most treatment-associated adverse events were mild to moderate in severity, occurred during the first eight weeks of treatment and incidence decreased over time. The most frequently reported adverse events in this trial were decreased appetite, headache, decreased weight and insomnia.

VYVANSE Demonstrated Consistent Time to Maximum Concentration of d-amphetamine from Patient to Patient

A once-daily 70 mg dose of VYVANSE provided low variability in the time from administration to maximum concentration of d-amphetamine from patient to patient. This finding was based on data from 17 children with ADHD aged 6 to 12 years enrolled in a double-blind phase II crossover trial examining the efficacy and safety of VYVANSE and mixed amphetamine salts extended release (MAS XR) in comparison to placebo.

Patients taking VYVANSE achieved maximum d-amphetamine concentration within a narrow time window of 4.5 to 6 hours. Patients taking MAS XR achieved maximum d-amphetamine concentration between 3 to 12 hours.


Contact: Marion E. Glick
Porter Novelli

Page: 1 2

Related medicine news :

1. Long-term anti-clotting therapy sweetens stenting outcomes in diabetic patients
2. Long-term aspirin use associated with reduced risk of dying in women
3. Long-term data on safety and effectiveness of antiobesity drugs needed
4. Long-term financial costs associated with prostate cancer treatment
5. Long-term effects of non-alcoholic fatty liver disease
6. Long-term outcomes for prostate cancer show IMRT Curative: 89 percent disease-free 8 years later
7. Long-term abstinence may resolve many of the neurocognitive deficits associated with alcoholism
8. Long-term safety results released for breast cancer drugs
9. Long-term ibuprofen regimen after brain injury worsens cognition in animal study
10. Media availability: Long-term survival of heart attack patients with shock
11. Long-term estrogen therapy linked to breast cancer risk

Post Your Comments:

(Date:2/19/2020)... NEEDHAM, Mass. (PRWEB) , ... February 19, 2020 ... ... improve the quality and consistency of healthcare delivery, announced that it will participate ... 13, 2020, in Orlando, Florida. BPM+ Health will engage healthcare professionals and other ...
(Date:2/16/2020)... PHOENIX (PRWEB) , ... February 16, 2020 , ... ... services, today announced that it is partnering with AABB and The Joint Commission ... on anemia management for PBM teams (directors, managers, coordinators and transfusion safety officers) ...
(Date:2/15/2020)... ... February 14, 2020 , ... It all started back in 2010, ... these heart-shaped characters and knew she was on to something special. The Heartsters ... through any life challenge including a health condition or illness, a disability or just ...
(Date:2/14/2020)... ... February 14, 2020 , ... “The American Society for ... texture and discoloration, and lines and wrinkles. And the treatments they are most ... great specials in February specifically to address the areas our patients are most ...
(Date:2/13/2020)... ... February 13, 2020 , ... President Trump recently released ... proposes substantial, damaging cuts to foreign affairs, global health, and global child vaccine ... slashes USAID global health programs by $3.1B, and significantly reduces funding for the ...
Breaking Medicine News(10 mins):
(Date:2/21/2020)... , ... February 21, 2020 , ... The business of ... staff, keeping up with industry trends and ensuring patients digital and physical safety, there ... the wayside. , That’s why MaintenX International’s is excited to provide their insights ...
(Date:2/20/2020)... ... February 20, 2020 , ... PAINWeekEnd ... Road, in Arizona, will be a timely and relevant 2-day program providing busy ... the management of chronic pain. , In 2020, paper prescriptions for certain painkillers ...
(Date:2/19/2020)... ... February 19, 2020 , ... Drs. Mario Canal and ... March 20, 2020 at The Mansion in Voorhees. The course features guest speaker, Dr. ... dental implants. Dental implants, including All-on-4® full mouth dental implants, are ...
Breaking Medicine Technology:
Cached News: